Nicole Jones

Investor Relations Kontakt bei ACHIEVE LIFE SCIENCES, INC.

Consumer Services

Finance

Health Technology

Profil

Nicole Jones is currently VP-Strategic Communications & IR Contact at Achieve Life Sciences, Inc. since 2025.
Formerly, Ms. Jones worked as an Analyst at Flyover Capital Partners LLC.
Ms. Jones completed undergraduate and graduate degrees at the University of Kansas.

Aktive Positionen von Nicole Jones

Unternehmen	Position	Beginn
ACHIEVE LIFE SCIENCES, INC.	Investor Relations Kontakt	01.08.2025

Alle aktiven Positionen von Nicole Jones

Ehemalige bekannte Positionen von Nicole Jones

Unternehmen	Position	Ende
Flyover Capital Partners LLC Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million.	Private-Equity-Analyst	-

Sehen Sie sich die Erfahrung von Nicole Jones im Detail an

Ausbildung von Nicole Jones

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Nicole Jones im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Flyover Capital Partners LLC Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million.	Finance
Achieve Life Sciences, Inc. Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction	Health Technology